Bourne Lent Asset Management’s Catheter Precision VTAK Stock Holding History

Bourne Lent Asset Management’s Portfolio VTAK Stock Details VTAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4	Closed	-$4K	–	64
2022 Q3	$4K	Hold	4	–	–	﹤0.01%	58
2022 Q2	$12K	Hold	4	–	–	﹤0.01%	61
2022 Q1	$15K	Buy	+4	New	+$27.2K	﹤0.01%	61
2020 Q4	–	Sell	-1	Closed	-$61K	–	62
2020 Q3	$61K	Hold	1	–	–	0.02%	55
2020 Q2	$104K	Hold	1	–	–	0.04%	53
2020 Q1	$230K	Hold	1	–	–	0.12%	47
2019 Q4	$202K	Buy	+1	New	+$305K	0.1%	59
2019 Q3	–	Hold	0	–	–	–	57

Other funds holding VTAK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

APC

Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return

Bourne Lent Asset Management's VTAK Position: Q4 2022 in Review

Bourne Lent Asset Management sold out of Catheter Precision (VTAK) in Q4 2022, closing a stake of 4 shares — an estimated $4K sold.

Bourne Lent Asset Management first reported a position in VTAK in Q4 2019 and held it in 7 quarters. The position peaked at $230K in Q1 2020. 9 funds tracked by Wall St. Rank hold VTAK as of Q4 2022.

Bourne Lent Asset Management reported no remaining Catheter Precision position as of Q4 2022 after selling out during the quarter.
Bourne Lent Asset Management sold 4 Catheter Precision shares in Q4 2022, an estimated $4K.
Bourne Lent Asset Management first reported a position in Catheter Precision in Q4 2019 and held it in 7 quarters.
Bourne Lent Asset Management's Catheter Precision position peaked at $230K in Q1 2020.
9 funds tracked by Wall St. Rank held Catheter Precision as of Q4 2022.

Based on Bourne Lent Asset Management's 13F filing for Q4 2022, filed 24 Jan 2023.